DAVID
GARCIA AZORIN
PROFESOR ASOCIADO
Hospital Universitario de la Princesa
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de la Princesa (17)
2024
-
Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study
Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202
-
Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
Frontiers in Neurology , Vol. 15
-
RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine
European Journal of Neurology, Vol. 31, Núm. 4
-
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937
-
Visual snow syndrome in patients with migraine: widening the clinical spectrum of the syndrome with permanent and episodic manifestations
Neurological Sciences, Vol. 45, Núm. 9, pp. 4437-4444
2022
-
Headache: What to ask, how to examine, and which scales to use. Recommendations of the Spanish Society of Neurology's Headache Study Group
Neurologia, Vol. 37, Núm. 7, pp. 564-574
-
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients
Cephalalgia, Vol. 42, Núm. 8, pp. 804-809
-
Thrombosis with thrombocytopenia syndrome following adenovirus vector-based vaccines to prevent COVID-19: Epidemiology and clinical presentation in Spain
Neurologia
2021
-
Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown
Neurological Sciences, Vol. 42, Núm. 12, pp. 5087-5092
-
Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine
Pain medicine (Malden, Mass.), Vol. 22, Núm. 9, pp. 2079-2091
-
Impact of the COVID-19 pandemic on the training of Spanish neurology residents
Neurology Perspectives, Vol. 1, Núm. 2, pp. 124-130
2020
-
Association Between Personality Traits and Onabotulinumtoxin A Response in Patients With Chronic Migraine
Headache, Vol. 60, Núm. 1, pp. 153-161
-
How and when to refer patients diagnosed with primary headache and craniofacial neuralgia in the Emergency department or Primary Care: Recommendations of the Spanish Society of Neurology's Headache Study Group
Neurologia
2019
-
CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA
Journal of Headache and Pain, Vol. 20, Núm. 1
-
Real world preventative drug management of migraine among Spanish neurologists
Journal of Headache and Pain, Vol. 20, Núm. 1
-
Self-reported periodontitis and migraine: results from a multicenter, cross-sectional survey in Spain
Odontology, Vol. 107, Núm. 4, pp. 530-535
-
Wearing off Response to OnabotulinumtoxinA in Chronic Migraine: Analysis in a Series of 193 Patients
Pain Medicine (United States), Vol. 20, Núm. 9, pp. 1815-1821